FOR IMMEDIATE RELEASE

Contact: Sharon Pizer                           
Phone: (202) 552-1476
E-mail: spizer@firelogic.com
http://www.firelogic.com

PARENTS CELEBRATE HIGH-TECH MEDICAL BREAKTHROUGH

(ARLINGTON, VA and LIVERMORE, CA) - Parents of asthmatics are celebrating worldwide as FireLogic, Inc. announces its new HealthEngage Software. The Software allows asthma sufferers to collect, store and chart vital health information. It can be used on PC’s, Mac’s, handheld devices such as Palm’s and web-enabled cellular phones. It is simple enough for kids and replaces paper diaries which are presently the only method available.

Tammy of Pennsylvania has watched her son’s progress since using the software.  “My son is nine years old and has had asthma since he was five.  He likes using the program to keep track of peak flows and medicine.  It is better for him to use this software as I cannot be with him all the time.  Also, the charts and other information help him to understand his illness better.  I would recommend this program to anyone with kids!”

Using this software, children will be better able to manage their healthcare and activities by having the ability to enter health information at any time from any place; they can be in school, at home or on vacation.  Medical doctors will also be able to review patient information in a more useful manner in simple charts and records and through online access.  A recent study showed that, with proper management, the number of asthma-related deaths could fall to almost zero; FireLogic believes that it has found that management tool.

A free trial version of the HealthEngage Asthma software can be downloaded at www.HealthEngage.com.  There are also special Back-to-School prices available throughout the month of August.

FireLogic began in 1998 and is comprised of scientists, physicians, and other professionals dedicated to helping chronically ill patients better manage their healthcare.  The firm has plans to release software for other chronic illnesses, such as hypertension and diabetes, in the near future.